DossierENTITY

non-Covid products

Coverage of non-Covid products in the Nexus archive.

Earliest in view: Aug 4 · 11:13 UTCMost recent: Aug 4 · 11:13 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSAug 4 · 11:13 UTCCNBC TOP
Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
Pfizer exceeded quarterly revenue estimates due to strong performance from non-Covid products and raised the lower end of its revenue guidance. However, the company reduced its full-year revenue forecast for Covid products to $4 billion from $5 billion.